As of 5th June 2026, researchers at the University of Cambridge and the university spinout company DIOSynVax (DVX) Ltd. have completed the phase 1 of human trials on a revolutionary piece of medical technology. Artificial intelligence has been used to develop type of vaccine that could protect against large swathes of viruses and even prevent pandemics! This vaccine was designed entirely by AI and was engineered to work on a broader Sars-Cov-2 family which would include all Covid variants as well.
How does this work? The Cambridge researchers took known genetic codes from a range of coronaviruses, which were then analyze by AI. It then designed a super- antigen that could train the immune system in such a way it gave protection against the whole family of viruses – even if they mutated.
Professor Jonathan Heeney, from the Cambridge University said this was the first time an antigen designed by AI had been trialled in people. Heeney told BBC News: This is about making vaccines that protect us, not just from today's viruses, but protect us from what can cause the next outbreak or disease. This is a fundamental shift in how we prepare for pandemics.
They are also looking at a vaccine for viral hemorrhagic fevers, which would include Ebola species. This line of research is wonderful news as we face the looming possibility of another pandemic caused by the outbreak in the Democratic Republic of the Congo.
Here’s a fun little word search as we wait for the brilliant scientists of the world to
bring us more uplifting and exciting news:
Words to Find:
COVID RESEARCH
VACCINE MUTATION
CAMBRIDGE PANDEMIC
VIRUS NEW
